OUR RESOURCES

All of Biotech and Money's content, in one place.

EXECUTIVE AND EXPERT INSIGHTS

PhoreMost raises £11m Series A round to progress targets into drug discovery

Key learnings: PhoreMost completed its Series A round in May 2018, with a t...

Read More

Medius Deal Watch May 2018

This month’s top deals are noticeably in the category of acquisitions rathe...

Read More

Five misconceptions about whistleblowing systems put to rest

Would you like to be able to identify risk - whether it be reputational, fi...

Read More

Aparito applies remote patient monitoring tech to dementia diagnosis

Key learnings: Wales-based digital health company Aparito utilises wearable...

Read More

Cognetivity’s AI-driven cognitive test seeks to address dementia diagnosis challenge

Key learnings: Cognetivity Neurosciences was named joint winner in the Inno...

Read More

Grace cooling device marries design and automation to relieve menopausal symptoms

Key learnings: Cooling device, Grace, won the Peri-Menopause Challenge cate...

Read More

Where can data and AI add value in healthcare and life sciences?

Artificial Intelligence (AI) is likely to have a profound impact in the hea...

Read More

New whistleblowing legislation proposed by European Commission

In the wake of various high profile international whistleblowing scandals, ...

Read More
View More

EXECUTIVE PUBLICATIONS AND REPORTS

Have your say in the LSX C-Suite Challenges in Life Sciences Survey 2018

What are the biggest obstacles to securing financing? What challenges do yo...

Read More

How to manage whistleblowing in life sciences

Whistleblowing, along with the impact that it can have on organisations, ha...

Read More

Infographic: Preparing for GDPR

Two years after gaining approval from the European Parliament, the General ...

Read More

INFOGRAPHIC: 2018 INVESTOR PERCEPTION SURVEY HIGHLIGHTS

This infographic presents key findings from the 2nd Biotech and Money Inves...

Read More

Read the Biotech and Money Investor Perception Survey 2018

The Investor Perception Survey 2018 is now available to download. The repor...

Read More

Infographic: 2017 Investor Perception Survey Highlights

In February 2017, Biotech and Money published its 1st Investor perception s...

Read More

A guide to successful investment in advanced therapies

The advanced therapy sector is a rapidly growing industry which offers subs...

Read More

Global therapeutic IPO market: Q3 2017 analysis

The global therapeutic IPO market has failed to maintain the upward momentu...

Read More
View More

INVESTORVIEWS

Investorview: Driving early-stage investment in UK life sciences

In March 2018, NCL Technology Ventures launched a £50 million fund to help ...

Read More

Investorview: Committing to social responsibility in healthcare investment

Swiss venture capital firm MTIP launched its first fund in 2016, achieving ...

Read More

Investor perspective: Sander Slootweg

Looking back at the past year, 2017 has proven to be a pretty successful ye...

Read More

Investorview: Proactively Bridging The Early Stage Funding Gap

Sinclair Dunlop, Managing Partner at Epidarex Capital Venture capital firm ...

Read More

Investorview: Dr Z Haroon on Julz Co’s recent investments

Julz Co focuses on healthcare investments across the US, Europe, and Asia-P...

Read More

Investorview - Edward Van Wezel, Managing Director, Biogeneration Ventures

We recently sat with Edward Van Wezel, Managing Director and Founder of Bio...

Read More

Investorview - Investing in a Digital Future with Christoph Ruedig, Partner, Albion Capital

Our latest investorview this week is with Christoph Ruedig, Partner at Albi...

Read More

Investorview – Precision Investing with Jay Goth, Managing Partner, Forentis Fund

Our latest investorview is, this week, with Jay Goth, Managing Partner of t...

Read More
VIEW MORE